Innovator IBD Breakout Opportunities ETF Rating $38.54 -0.06 (-0.16%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$38.56 +0.02 (+0.05%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Innovator IBD Breakout Opportunities ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BOUT Aggregate RatingModerate Buy 2.74Holdings in BOUT have an aggregate rating of Moderate Buy based on 319 analyst ratings issued in the past year covering 23 companies (72.5% of the portfolio).BOUT Aggregate Price Target$38.54High Prediction$38.54Average Prediction$38.54Low Prediction$38.54Holdings in BOUT have an aggregate price target of $38.54 and a range of $38.54 to $38.54 covering 23 companies (72.5% of the portfolio).BOUT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD Breakout Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 BOUT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.95%MDGLMadrigal Pharmaceuticals$432.22-1.6%4.2054 of 5 stars2.90$483.38 11.8%10Analyst Forecast3.87%SRADSportradar Group$30.33+1.1%3.0721 of 5 stars2.84$31.41 3.6%19Analyst Forecast3.86%UMBFUMB Financial$120.60-0.9%4.9115 of 5 stars2.78$133.89 11.0%9Positive News3.83%APPAppLovin$582.00+1.9%2.6723 of 5 stars2.88$496.48 -14.7%24Trending NewsAnalyst Forecast3.76%SCHWCharles Schwab$93.50-0.5%4.8398 of 5 stars2.67$99.60 6.5%21Positive News3.70%GOOGLAlphabet$240.80+0.2%3.8865 of 5 stars2.84$221.44 -8.0%45Trending NewsAnalyst Upgrade3.70%MTZMasTec$189.74+0.3%3.7683 of 5 stars3.10$196.22 3.4%20Positive NewsAnalyst Downgrade3.59%MWAMueller Water Products$25.06-1.6%4.6424 of 5 stars2.33$28.33 13.1%3Positive News3.50%THCTenet Healthcare$192.60-0.4%4.6634 of 5 stars2.84$195.50 1.5%19Insider Trade3.42%ATGEAdtalem Global Education$137.33-0.9%4.4871 of 5 stars2.75$139.00 1.2%4Positive News3.41%SKYWSkyWest$107.66-1.5%4.4056 of 5 stars3.00$126.75 17.7%4Positive News3.28%GVAGranite Construction$107.43-2.0%1.3079 of 5 stars1.00$76.00 -29.3%1Positive NewsDividend Announcement3.23%COFCapital One Financial$223.59-0.3%4.9747 of 5 stars2.95$239.44 7.1%20News CoveragePositive NewsAnalyst Forecast3.23%KTOSKratos Defense & Security Solutions$69.20+2.3%2.44 of 5 stars2.94$57.64 -16.7%16News CoveragePositive News3.21%APGAPi Group$34.90-2.0%2.9972 of 5 stars3.00$36.10 3.4%8Positive News3.18%ENVAEnova International$115.10-2.0%2.1877 of 5 stars3.17$111.00 -3.6%62.33%LIFLife360$100.24+2.0%1.3585 of 5 stars3.00$86.43 -13.8%72.28%AMZNAmazon.com$228.15-0.8%4.8763 of 5 stars3.00$262.87 15.2%50Trending News2.24%YMMFull Truck Alliance$13.60-1.4%3.2799 of 5 stars2.80$15.00 10.3%5Positive News2.23%LRNStride$158.36-1.7%2.9008 of 5 stars2.67$146.40 -7.6%6News CoveragePositive News2.23%MODModine Manufacturing$149.47+1.8%2.5362 of 5 stars3.00$145.67 -2.5%32.22%INCYIncyte$83.10-3.6%4.7408 of 5 stars2.33$82.53 -0.7%18Positive NewsAnalyst DowngradeShort Interest ↓2.20%NBNNortheast Bancorp$110.40-0.5%2.8218 of 5 stars2.00$115.00 4.2%1Positive News This page (NYSEARCA:BOUT) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
